Cineplex Hits Its Leverage Target and Stops Talking
A record quarter, a first-time CEO, and a strategic review that absorbs every capital-allocation question before it can be answered
CGX.TO · Earnings Call · 2026-11-06
The best quarter in company history, and the least informative call in a year
Cineplex delivered something genuinely rare for this name: an all-time high in quarterly revenue. Revenue came in at $440.2 million, up 20.2%; attendance rose 23.1% to 14.8 million guests; adjusted EBITDA more than doubled to $70.7 million from $33.3 million; adjusted free cash flow tripled to $52.9 million. Box office per patron crossed $14 for the first time ever, and premium formats — IMAX, UltraAVX, VIP — accounted for 51.4% of box office, with the eight IMAX 70mm houses selling out repeatedly for The Odyssey. New CEO Bill Walker, on his first earnings call, did not underplay it: “Not only did we deliver our highest quarterly revenue of all time, but our adjusted EBITDA more than doubled year over year.” — Bill Walker, Chief Executive Officer · 2026-11-06
And yet the most consequential number on the page was the one buried in the leverage discussion. The simple leverage ratio finished at 2.9x — inside the 2.5x to 3.0x target range management had been pointing at for over a year. Since 2024, the company has taken roughly 2.6 turns out of that ratio. The balance-sheet repair story is, functionally, complete.
Which makes what happened next the actual story.
Review purgatory swallows the capital-return conversation
The first analyst question was about the strategic review. The answer was a polite wall: “we are really not able to provide updates on the review process... that includes a really broad range of options we are not going to be able to provide an update on exactly where we are at in that process or a specific timeline for the process.” — Bill Walker, Chief Executive Officer · 2026-11-06 The second question was the obvious follow-on — if leverage is now in range, is a dividend or a bigger buyback possible before the review concludes? “hitting our target leverage, ratio range is a key milestone for us. What it does is it creates additional flexibility as we look forward.” — Gord Nelson, Chief Financial Officer · 2026-11-06 Flexibility, but no decision.
This is where the keyword record is unusually blunt. strategic review is the company's number-one keyword this quarter — a phrase that did not appear anywhere in the prior twelve quarters of Cineplex's curated keyword list. It has displaced the old obsession: target leverage, which was the number-two theme just two quarters ago, has slid down the table. So has builder basket capacity, the technical mechanism Gord Nelson painstakingly explained to analysts in August. The company has migrated from fixing the balance sheet to deciding what the company is.
I would say both of them are on the table... But at this point in time, you know, I am just going to say that both of those are on the table and a focus. But we are not gonna provide sort of the levels between the 2 of them at this point.
That was August. Nelson also said then that if the industry delivered the roughly $10 billion domestic box office everyone was forecasting, Cineplex would be in its target range "with the reporting, the big sort of the Q4 results" — and that the builder basket opens once cumulative EBITDA since January 2024 covers more than 1.75x fixed interest charges of about $60 million a year. The industry did deliver; Cineplex got there a quarter early. The basket is open, or nearly so. And the answer is still: we will evaluate. The review has become the answer to every question, including the ones it was never meant to cover.
The content inflection is now contractual, not just hopeful
What genuinely changed in the industry this quarter is that the studio commitments hardened. Walker flagged that as part of the Paramount–Warner combination, Skydance has committed to a minimum of 30 annual theatrical releases, a minimum 45-day exclusive theatrical window, and no changes to film rental terms. That last clause is the one that matters for the P&L: film cost creep has been a recurring analyst complaint for at least three quarters — Drew Reichert pressed on it in February, Adam Shine in August, both getting the same "film cost is driven by the performance of the films" answer. This quarter, nobody asked. A structural answer tends to end a structural question.
The demand evidence is strong. October box office rose 42% year over year, helped by the documentary You Can See Everything; year-to-date box office through October is up 25% against domestic industry growth of 21%, and has already surpassed Cineplex's full-year 2025 total with two months left. box office revenue ranks near the top of the keyword table, alongside film slate and content supply — the latter a phrase that has been circulating in Cineplex's keyword history since 2024 but has only now acquired signed terms behind it. theatrical release windows are no longer an industry hope; they are a contractual floor.
There is a second-order change worth flagging: Netflix is now a theatrical distributor, with Narnia: The Magician's Nephew slated for early 2027, and horror titles like Backrooms and Session are pulling digital-native, Gen Z-skewing audiences into cinemas. The old exhibitor fear was that streaming would absorb the window. The new reality is that Netflix is helping fill it. The read-across to IMAX's own report this week — which cited demand for IMAX and premium-format strength — is consistent: the premium end of exhibition is where the economics are concentrating.
The two soft spots nobody is pretending away
Media was flat. Revenue held, adjusted EBITDA was $15.1 million at a 79.5% margin, and management was explicit about why: advertiser budgets front-loaded into the first half around the Olympics and the World Cup, plus a brutal prior-year comparison against weight-loss-drug pharmaceutical spending that has since rolled off. Nelson's Q4 setup: “spending has been front-end loaded... as we sit here today in November, with no real resolution on those as the spending is not going to be opened up for the remainder of Q4.” — Gord Nelson, Chief Financial Officer · 2026-11-06 The 2027 media recovery is explicitly contingent on tariff resolution and consumer confidence — a macro bet dressed as a segment outlook.
LBE remains the fixer-upper. Revenue of $34.0 million was down 1.7%, though adjusted store-level EBITDA improved and segment EBITDA actually rose to $4.8 million from $4.6 million on cost discipline. The new Playdium in Vaughan is performing well. Walker was candid that he is still in discovery mode on the LBE side, describing Rec Room and Playdium as "a platform that has a ton of potential" while offering no 2027 growth plan. Honest, but not yet an answer.
What to watch
Three things. First, whether the review produces a transaction or a standalone plan with a capital return attached — the stock is a roughly C$636 million market cap, so the outcome is close to binary for equity holders. Second, Q4 working capital: holiday gift-card and certificate sales historically provide a cash benefit, and management expects further deleveraging by year-end, which would expand the basket and, in theory, remove the last technical excuse. Third, the 2027 slate, which Walker called "really constructive" on quantity, window consistency, and studio marketing commitment, with a December 2026 carryover into Q1.
The quarter proved the operating leverage is real — roughly $14 of incremental EBITDA per additional guest, in line with the long-standing framework. What it did not prove is that Cineplex's board and its new CEO are ready to tell shareholders what they intend to do with the cash that leverage is about to free up. That silence is the story.